U.S. Court of Appeals for the Federal Circuit
Amgen Inc. v. Sandoz Inc.
This writing
- Type
- Opinion
- Filed
- April 19, 2023
- Case
- Amgen Inc. v. Sandoz Inc.
- Case status
- Decided
Source No authoring judge could be established for this writing, either from provider metadata or from the signature line of the court's published opinion. Benchlight shows the gap rather than guessing at an author.
Opening text
The first passage of the document, as extracted by the source provider.
Case: 22-1147 Document: 60 Page: 1 Filed: 04/19/2023 United States Court of Appeals for the Federal Circuit ______________________ AMGEN INC., Plaintiff-Cross-Appellant v. SANDOZ INC., ZYDUS PHARMACEUTICALS (USA) INC., Defendants-Appellants MANKIND PHARMA LTD., TORRENT PHARMACEUTICALS LTD., GLENMARK PHARMACEUTICALS LIMITED, MACLEODS…
Source Extract supplied by CourtListener. Benchlight does not host the document — read the authoritative text in the court's own PDF.